Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on ...

Fumarate therapies are equally effective among Black, Hispanic, Asian, and white people with relapsing forms of MS, a real-world study shows.

People with multiple sclerosis (MS) may have slightly shorter-than-average life spans, depending on disease severity, ...

Almost 3 million people worldwide have multiple sclerosis. Muhammad Taimur Malik, MD, of St. Luke’s Neurology Associates ...

The first sign of multiple myeloma varies by person and may not occur until a later stage of the disease. Learn how to ...

Antonella Favit-Van Pelt, MD, PhD, discusses the use of neuromodulation and neuroplasticity for addressing gait deficits in patients with multiple sclerosis.

In relapsing-remitting multiple sclerosis, activation of the peripheral immune system can lead to focal inflammation within the CNS. Over the past three decades, therapeutic development has been ...

Multiple sclerosis, the prototype of demyelinating disease in man, is a relapsing-remitting or progressively disabling disease of unknown cause. The first pathological descriptions of the disease ...

In part 2, Hans Lee, MD, shares practical tips for using linvoseltamab in heavily pretreated multiple myeloma and outlines ...

The newly approved linvoseltamab (Lynozyfic; Regeneron) has a manageable safety profile, along with a patient-friendly dosing ...

Some vitamins and herbal supplements may help to relieve MS symptoms, but others are ineffective and might even be harmful. Learn which is which.

Researches at the University of Cincinnati's Gardner Neuroscience Institute could have discovered a new oral treatment that ...